Inhibikase Therapeutics (IKT) Interest Coverage Ratio Growth (1y) (2021 - 2022)
Inhibikase Therapeutics (IKT) Interest Coverage Ratio Growth (1y) (2021 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
67.94% |
| 10 |
Inhibikase Therapeutics |
285.17 Mn |
114.80 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2022 |
-416,962.55% |
| Dec 31, 2021 |
-18,869.20% |
| Sep 30, 2021 |
-29,463.13% |
| Jun 30, 2021 |
-546.13% |
| Mar 31, 2021 |
-205.98% |
